FDA grants clearance of Insulcloud's Insulclock® pro injection data capture
Home News FDA grants clearance of Insulcloud's Insulclock® pro injection data capture

FDA grants clearance of Insulcloud's Insulclock® pro injection data capture

SEPTEMBER 25, 2024 BHH Members Initiatives

BHH member Insulcloud is pleased to announce that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Insulclock® pro device within the United States. This clearance is a testament to Insulcloud's commitment to quality and innovation in the healthcare industry.

Insulclock® pro is a reusable medical device with Software Development Kit (SDK) that detects and stores insulin dose-related data when attached to a disposable insulin pen and then transfers information to a compatible mobile application via Bluetooth® wireless technology which can display the brand of insulin, dose amount, injection date, injection time, and ambient temperature. Insulclock® pro is indicated for use by patients using disposable insulin diagnosed with type I or type II diabetes mellitus.

With this significant milestone, Insulcloud is now authorized to enter the U.S. market, providing healthcare professionals and patients with access to their state-of-the-art medical device. The FDA's clearance underscores the safety, efficacy, and quality of Insulclock® pro, and represents a key step in Insulcloud’s global expansion strategy.

This development will enable Insulcloud to strengthen their relationships with current and future partners, ensuring that their products reach those who need them most.

Discover more about Insulclock® at their website HERE

September 27, 2024 BHH Members Initiatives
Meet BHH provider Roberta Giannini
Roberta’s expertise lies in identifying new business opportunities and designing custom solutions that align with market trends and customer needs.
Read more
September 27, 2024 BHH Members Initiatives
Recruit experienced students from Master’s Degree in Health Data Science (MHEDAS) for internships
BHH partner Universitat Rovira i Virgili (URV)/EIT Health is calling out for companies, research centers, hospitals and institutions to host internships for the students of their Master’s Degree in Health Data Science (MHEDAS).
Read more
September 26, 2024 BHH Members Initiatives
Asabys announces the closing of €180M oversubscribed Sabadell Asabys II Fund
Similar to Sabadell Asabys Fund I, the Fund II portfolio will include companies within the fields of biopharma, medtech and digital health that provide a clear benefit for patients.
Read more
September 25, 2024 BHH Members Initiatives
Senniors moves to Barcelona Health Hub to drive innovation in home healthcare
The demand for elderly and dependent care is projected to grow by 513.45% in Barcelona in 2024, prompting Senniors to relocate its offices to the Barcelona Health Hub.
Read more
September 25, 2024 BHH Members Initiatives
FDA grants clearance of Insulcloud's Insulclock® pro injection data capture
Insulclock® pro is a reusable medical device with Software Development Kit (SDK) that detects and stores insulin dose-related data.
Read more
September 19, 2024 BHH Members Initiatives
H-FABP as a Biomarker for Transient Ischemic Attack
ABCDx has harnessed this groundbreaking research to develop VasCheck, a rapid test utilizing H-FABP, designed for point-of-care testing.
Read more
September 18, 2024 BHH Members Initiatives
The first Catalan-specific voice recognition model for healthcare has been developed
Hospital Clínic de Barcelona and VÓCALI collaborate to create a pioneering speech-to-text model for healthcare in catalan.
Read more
September 12, 2024 BHH Members Initiatives
Qualifyze Raises $54m to Boost Supplier Risk Management in Life Sciences
Qualifyze announced $54 million in Series B funding from global software investor Insight Partners. With the new funding, Qualifyze aims to expand its operations into the US market, continue investing in its go to market strategy, and enhance its technology to improve supplier risk management globally.
Read more
September 10, 2024 BHH Members Initiatives
Deepull bets on a WOW customer journey with eMascaró
Deepull is moving towards the future of health with its recent collaboration with the agency eMascaró, specialized in the development of digital projects for the sector.
Read more
September 10, 2024 BHH Members Initiatives
Digitising a health industry with a stronger emotional connection
The healthcare industry is undergoing a pivotal stage in its evolution, marked by significant changes stemming from numerous sources: social, technological, economic, scientific, and more.
Read more